As the advanced PCa tissue harbors enhanced NRF2-NQO1 levels as compared to the normal prostate tissue, to cope with increased oxidative stress, β-Lapachone may have a better efficacy to reduce NRF2 selectively in cancer tissue. This evidence concerns the gene NFE2L2 and posterior cortical atrophy.